US4061897A
(en)
*
|
1976-01-23 |
1977-12-06 |
Audrae Thykeson |
Heating pad
|
US4571333A
(en)
*
|
1983-06-14 |
1986-02-18 |
Syntex (U.S.A.) Inc. |
Controlled release naproxen and naproxen sodium tablets
|
US4695591A
(en)
*
|
1985-03-29 |
1987-09-22 |
Schering Corporation |
Controlled release dosage forms comprising hydroxypropylmethylcellulose
|
US4734285A
(en)
*
|
1985-10-28 |
1988-03-29 |
The Dow Chemical Company |
Sustained release compositions
|
US5527545A
(en)
*
|
1989-09-18 |
1996-06-18 |
Recordati S.A. Chemical And Pharmaceutical Company |
Liquid-suspension controlled-release pharmaceutical composition
|
IT1256651B
(it)
*
|
1992-12-11 |
1995-12-12 |
Giancarlo Santus |
Composizione farmaceutica a rilascio controllato in sospensione liquida
|
IE66933B1
(en)
*
|
1990-01-15 |
1996-02-07 |
Elan Corp Plc |
Controlled absorption naproxen formulation for once-daily administration
|
US5198227A
(en)
*
|
1990-01-22 |
1993-03-30 |
Mcneil-Ppc, Inc. |
Dual subcoated simulated capsule medicament
|
US5204116A
(en)
*
|
1991-05-01 |
1993-04-20 |
Alza Corporation |
Dosage form providing immediate therapy followed by prolonged therapy
|
US5225201A
(en)
*
|
1991-08-23 |
1993-07-06 |
Minnesota Mining And Manufacturing Company |
Salsalate tablet
|
DE4140172C2
(de)
*
|
1991-12-05 |
1995-12-21 |
Alfatec Pharma Gmbh |
Retardform für ein Ibuprofen enthaltendes Arzneimittel
|
DE4140183C2
(de)
*
|
1991-12-05 |
1995-12-21 |
Alfatec Pharma Gmbh |
Retardform für ein Flurbiprofen enthaltendes Arzneimittel
|
DE4140185C2
(de)
*
|
1991-12-05 |
1996-02-01 |
Alfatec Pharma Gmbh |
Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung
|
DE4140184C2
(de)
*
|
1991-12-05 |
1995-12-21 |
Alfatec Pharma Gmbh |
Akutform für ein Flurbiprofen enthaltendes Arzneimittel
|
IL104192A
(en)
*
|
1992-02-17 |
1998-01-04 |
Siegfried Ag Pharma |
Pharmaceutical dosage forms having prolonged release rate of zero order of the active ingredient
|
ATE135214T1
(de)
*
|
1992-02-17 |
1996-03-15 |
Siegfried Ag Pharma |
Darreichungsformen mit verlaengerter wirkstoffreigabe
|
WO1993017673A1
(en)
*
|
1992-03-03 |
1993-09-16 |
Top Gold Pty., Limited |
Sustained release analgesics
|
DE4226753A1
(de)
*
|
1992-08-13 |
1994-02-17 |
Basf Ag |
Wirkstoffe enthaltende Zubereitungen in Form fester Teilchen
|
US5609884A
(en)
*
|
1992-08-31 |
1997-03-11 |
G. D. Searle & Co. |
Controlled release naproxen sodium plus naproxen combination tablet
|
RU2121830C1
(ru)
*
|
1992-09-18 |
1998-11-20 |
Яманоути Фармасьютикал Ко., ЛТД |
Гидрогелевый препарат с длительным высвобождением лекарства
|
US6129930A
(en)
|
1993-09-20 |
2000-10-10 |
Bova; David J. |
Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
|
US6676967B1
(en)
*
|
1993-09-20 |
2004-01-13 |
Kos Pharmaceuticals, Inc. |
Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
|
US20060263428A1
(en)
*
|
1993-09-20 |
2006-11-23 |
Eugenio Cefali |
Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
|
US6746691B2
(en)
|
1993-09-20 |
2004-06-08 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
|
US6818229B1
(en)
|
1993-09-20 |
2004-11-16 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia
|
US6080428A
(en)
|
1993-09-20 |
2000-06-27 |
Bova; David J. |
Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
|
US5484607A
(en)
*
|
1993-10-13 |
1996-01-16 |
Horacek; H. Joseph |
Extended release clonidine formulation
|
US6096920A
(en)
*
|
1997-01-08 |
2000-08-01 |
Albemarle Corporation |
Preparation of carboxylic compounds and their derivatives
|
US6080888A
(en)
*
|
1997-01-08 |
2000-06-27 |
Albemarle Corporation |
Preparation of olefinic compounds and carboxylic derivatives thereof
|
US5792886A
(en)
*
|
1997-01-08 |
1998-08-11 |
Albemarle Corporation |
Production of racemic 2-(6-methoxy-2-naphthyl) propionic acid of precursors thereof
|
US5874614A
(en)
*
|
1997-12-11 |
1999-02-23 |
Albemarle Corporation |
Sodium (S)-2-(6-methoxy-2-naphthyl)propionate monohydrate
|
US5859292A
(en)
*
|
1997-12-11 |
1999-01-12 |
Albemarle Corporation |
Preparation of high purity sodium (S)-2(6-methoxy-2-naphthyl)propionate
|
US7235258B1
(en)
*
|
1999-10-19 |
2007-06-26 |
Nps Pharmaceuticals, Inc. |
Sustained-release formulations for treating CNS-mediated disorders
|
US7371397B2
(en)
*
|
2000-01-18 |
2008-05-13 |
Albemarle Corporation |
Methods for microbiological control in aqueous systems
|
US6495698B1
(en)
|
2000-01-18 |
2002-12-17 |
Albemarle Corporation |
Binder-free compacted forms of 1,3-dihalo-5,5-dimethylhydantoins
|
US6638959B2
(en)
|
2000-01-18 |
2003-10-28 |
Albemarle Corporation |
Microbiological control in aqueous systems
|
US6680070B1
(en)
|
2000-01-18 |
2004-01-20 |
Albemarle Corporation |
Particulate blends and compacted products formed therefrom, and the preparation thereof
|
US6448410B1
(en)
|
2000-01-18 |
2002-09-10 |
Albemarle Corporation |
Production of compacted biocidal agent from particulate biocidal agent without using a binder
|
US6809205B1
(en)
|
2000-01-18 |
2004-10-26 |
Albemarle Corporation |
Process for producing N-halogenated organic compounds
|
US20050049420A1
(en)
*
|
2000-01-18 |
2005-03-03 |
Elnagar Hassan Y. |
Process for producing N-halogenated organic compounds
|
US7579018B2
(en)
*
|
2000-01-18 |
2009-08-25 |
Albemarle Corporation |
Microbiological control in aqueous systems
|
US6565868B1
(en)
|
2000-01-18 |
2003-05-20 |
Albemarle Corporation |
Methods for microbiological control in aqueous systems
|
US6508954B1
(en)
|
2000-01-18 |
2003-01-21 |
Albemarle Corporation |
1,3-dibromo-5,5-dimethylhydantoin of enhanced properties
|
US7999118B2
(en)
*
|
2000-01-18 |
2011-08-16 |
Albemarle Corporation |
Process for producing N-halogenated hydantoins
|
WO2003011033A1
(en)
*
|
2001-06-28 |
2003-02-13 |
Solution Biosciences, Inc. |
Microbiological control in animal processing
|
US6919364B2
(en)
*
|
2001-06-28 |
2005-07-19 |
Solution Biosciences, Inc. |
Microbiological control in animal processing
|
US6986910B2
(en)
*
|
2001-06-28 |
2006-01-17 |
Albemarle Corporation |
Microbiological control in poultry processing
|
US6673369B2
(en)
|
2001-08-29 |
2004-01-06 |
Ranbaxy Laboratories Limited |
Controlled release formulation
|
EP1423097A1
(en)
*
|
2001-08-29 |
2004-06-02 |
Ranbaxy Laboratories, Ltd. |
Controlled release formulation of clarithromycin or tinidazol
|
WO2003031347A1
(en)
*
|
2001-10-09 |
2003-04-17 |
Albemarle Corporation |
Control of biofilms in industrial water systems
|
US6602911B2
(en)
*
|
2001-11-05 |
2003-08-05 |
Cypress Bioscience, Inc. |
Methods of treating fibromyalgia
|
AU2003225837B2
(en)
*
|
2002-03-15 |
2008-11-06 |
Forest Laboratories Holdings Limited |
NE and 5-HT reuptake inhibitors for treating visceral pain syndromes
|
US20040010024A1
(en)
*
|
2002-07-10 |
2004-01-15 |
Howarth Jonathan N. |
Particulate blends and compacted products formed therefrom, and the preparation thereof
|
US6965035B1
(en)
|
2002-07-25 |
2005-11-15 |
Albemarle Corp |
Compacted forms of halogenated hydantoins
|
US20040121010A1
(en)
*
|
2002-10-25 |
2004-06-24 |
Collegium Pharmaceutical, Inc. |
Pulsatile release compositions of milnacipran
|
US20060003004A1
(en)
*
|
2002-10-25 |
2006-01-05 |
Collegium Pharmaceutical, Inc. |
Pulsatile release compositions of milnacipran
|
US20040228918A1
(en)
*
|
2003-01-02 |
2004-11-18 |
Chih-Ming Chen |
Granule modulating hydrogel system
|
AU2004207578B2
(en)
*
|
2003-01-28 |
2007-06-28 |
Collegium Pharmaceutical, Inc. |
Multiparticulate compositions of milnacipran for oral administration
|
US20040185093A1
(en)
*
|
2003-03-18 |
2004-09-23 |
Szymczak Christopher E. |
Compositions containing sucralose
|
US20060105036A1
(en)
|
2003-05-12 |
2006-05-18 |
Stephen Peroutka |
Threo-dops controlled release formulation
|
US8158149B2
(en)
*
|
2004-05-12 |
2012-04-17 |
Chelsea Therapeutics, Inc. |
Threo-DOPS controlled release formulation
|
US7901276B2
(en)
*
|
2003-06-24 |
2011-03-08 |
Albemarle Corporation |
Microbiocidal control in the processing of meat-producing four-legged animals
|
US20040265446A1
(en)
*
|
2003-06-24 |
2004-12-30 |
Mcnaughton James L. |
Microbiocidal control in the processing of poultry
|
US20040265445A1
(en)
*
|
2003-06-24 |
2004-12-30 |
Liimatta Eric W. |
Microbiocidal control in the processing of poultry
|
US20070092566A1
(en)
*
|
2003-08-04 |
2007-04-26 |
Ryouichi Hoshino |
Oral sustained-release tablet
|
US20060062811A1
(en)
*
|
2004-09-21 |
2006-03-23 |
Szymczak Christopher E |
Medicinal cooling emulsions
|
CN101115392B
(zh)
*
|
2004-12-23 |
2011-05-11 |
雅宝公司 |
产肉四足动物加工中的杀微生物控制
|
US7994220B2
(en)
*
|
2005-09-28 |
2011-08-09 |
Cypress Bioscience, Inc. |
Milnacipran for the long-term treatment of fibromyalgia syndrome
|
BRPI0620851B1
(pt)
*
|
2005-12-01 |
2016-08-23 |
Albemarle Corp |
método para controle microbiano no processo de produção de carne de animais quadrúpedes
|
US20090087490A1
(en)
*
|
2007-06-08 |
2009-04-02 |
Addrenex Pharmaceuticals, Inc. |
Extended release formulation and method of treating adrenergic dysregulation
|
US20100172991A1
(en)
*
|
2007-06-08 |
2010-07-08 |
Henry Joseph Horacek |
Extended Release Formulation and Methods of Treating Adrenergic Dysregulation
|
AR082189A1
(es)
|
2010-07-06 |
2012-11-21 |
Gruenenthal Gmbh |
Formas de dosificacion gastrorretentivas, procedimiento
|
US9415048B2
(en)
*
|
2010-07-08 |
2016-08-16 |
Wellesley Pharmaceuticals, Llc |
Pharmaceutical formulation for reducing frequency of urination and method of use thereof
|
US20120244218A1
(en)
|
2011-03-25 |
2012-09-27 |
Durkee Shane E |
Calcium supplement
|
CN106880614A
(zh)
*
|
2017-04-06 |
2017-06-23 |
地奥集团成都药业股份有限公司 |
一种萘普生缓释片及其制备方法
|